Commissioner Marty Makary on Monday denied recent reports suggesting plans for his agency to add a black box warning onto ...

The pharmaceutical company updated its sales guidance for 2025, saying it now expects $62 billion in revenue for the year.

Pfizer said revenue should come in at the lower end of its guidance for this year, while it expects less revenue in 2026 than in 2025, as the drugmaker's efforts to remake its business continue to ...

Pfizer Inc. forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit ...

Amid profit forecast reductions, Pfizer is implementing a $7.7bn cost-cutting strategy, while investing into its ...

Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...

Officials said they were considering such a move last week, but the plan was widely condemned by health experts.

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.

Pregnant women who get the COVID-19 vaccine are less likely to have a preterm birth, University of British Columbia ...

Pfizer CEO Albert Bourla defended his company’s vaccine business as rhetoric from HHS Secretary Robert F. Kennedy Jr. drives ...

Paxlovid, an FDA-approved oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it as soon as possible ...

Pfizer shares fell after the company issued weaker-than-expected 2026 guidance, citing lower demand for COVID-19 products and ...